Vaso Corporation (VASO)
OTCMKTS · Delayed Price · Currency is USD
0.1740
+0.0040 (2.35%)
Jan 8, 2026, 10:38 AM EST
Vaso Corporation Revenue
Vaso Corporation had revenue of $22.66M in the quarter ending September 30, 2025, with 9.09% growth. This brings the company's revenue in the last twelve months to $89.11M, up 9.14% year-over-year. In the year 2024, Vaso Corporation had annual revenue of $86.77M with 7.09% growth.
Revenue (ttm)
89.11M
Revenue Growth
+9.14%
P/S Ratio
0.34
Revenue / Employee
299.03K
Employees
298
Market Cap
29.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 86.77M | 5.74M | 7.09% |
| Dec 31, 2023 | 81.02M | 1.73M | 2.18% |
| Dec 31, 2022 | 79.29M | 3.72M | 4.92% |
| Dec 31, 2021 | 75.58M | 5.73M | 8.20% |
| Dec 31, 2020 | 69.85M | -5.67M | -7.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |
Vaso Corporation News
- 16 days ago - The Zacks Analyst Blog Highlights Eli Lilly, Shell, ICICI Bank, Frequency Electronics and Vaso - Nasdaq
- 22 days ago - Vaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCare - GlobeNewsWire
- 7 weeks ago - Vaso Stock Up Following Strong Q3 Earnings and Profit Turnaround - Nasdaq
- 7 weeks ago - Vaso announces divestiture of VasoHealthcare for $0.8M - Seeking Alpha
- 7 weeks ago - Vaso Corporation Announces Divestiture of Subsidiary - GlobeNewsWire
- 7 weeks ago - VASO Posts Strong Q3 2025 Financial Results with Revenue and Income Growth - GuruFocus
- 7 weeks ago - Vaso Corporation Announces Financial Results for Third Quarter of 2025 - GlobeNewsWire
- 4 months ago - The Zacks Analyst Blog Highlights Roche, Linde, Disney and Vaso - Nasdaq